PTN - Promising News and upcoming CatalystsPalatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.63 USD
−17.31 M USD
0.00 USD
1.40 M
About Palatin Technologies, Inc.
Sector
Industry
CEO
Carl Spana
Website
Headquarters
Princeton
Founded
1986
ISIN
US6960776010
FIGI
BBG000BN9PY4
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.
Related stocks
☆ PTN possible bullish flag ☆ Enter if it breaks this flag/triangle pattern on the 15-1 hr timeframe, putting your stop loss just below the candle you enter on. Close some of your position after a few hours. Close the entire position when price closes below the 10 SMA.
sorry I meant to tag this as "long"
~this is just an idea~
Bullish Cypher Pattern on PTN ChartThis pattern gives a first target to return to level A at about 8.10-8.20 and a second target to return to level C at around 8.50.
Anticipated Catalysts for remaining 2022:
NA/US Licensing Vyleesi
ROW Licensing Vyleesi
PL3994 PH2 Heart Failure Data
Diabetic Nephropathy PH 2 Initiate Study
$PTN entry PT .70-.75 Target PT 1.59 Long term PT 5 and higher$PTN H.C. Wainwright analyst Joseph Pantginis is behind today’s news as he reiterated the firm’s buy rating for PTN stock. To go along with that, Pantginis also increased the price target for PTN stock from $2 per share to $5 per share, 1,371% upside
Palatin Technologies, Inc., a biopharmaceutical
Palatin Technologies 500%+ Expected ReturnCompany Profile
Sector: Health Care
Industry: Biotechnology
Company Location: Cranbury, NJ
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PTN is 12.73 USD — it has increased by 17.87% in the past 24 hours. Watch Palatin Technologies, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Palatin Technologies, Inc. stocks are traded under the ticker PTN.
PTN stock has risen by 59.13% compared to the previous week, the month change is a 81.34% rise, over the last year Palatin Technologies, Inc. has showed a −76.21% decrease.
PTN stock is 25.99% volatile and has beta coefficient of 0.12. Track Palatin Technologies, Inc. stock price on the chart and check out the list of the most volatile stocks — is Palatin Technologies, Inc. there?
Today Palatin Technologies, Inc. has the market capitalization of 15.36 M, it has increased by 91.50% over the last week.
Yes, you can track Palatin Technologies, Inc. financials in yearly and quarterly reports right on TradingView.
Palatin Technologies, Inc. is going to release the next earnings report on Feb 17, 2026. Keep track of upcoming events with our Earnings Calendar.
PTN net income for the last quarter is 4.68 M USD, while the quarter before that showed −2.23 M USD of net income which accounts for 309.77% change. Track more Palatin Technologies, Inc. financial stats to get the full picture.
No, PTN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 18, 2025, the company has 29 employees. See our rating of the largest employees — is Palatin Technologies, Inc. on this list?
Like other stocks, PTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Palatin Technologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Palatin Technologies, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Palatin Technologies, Inc. stock shows the sell signal. See more of Palatin Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









